• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

READ THE DIARIES: Documents unveil Fauci’s thoughts on the lab-leak debate, mask doubts and testing failures

by July 28, 2026
written by July 28, 2026

Sen. Rand Paul, R-Ky., on Tuesday released the private diaries of Dr. Anthony Fauci, the controversial former director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief government spokesperson during the COVID-19 pandemic.

The released documents show Fauci privately confronted possibilities about the virus’s origins that he publicly downplayed. On Jan. 31, 2020, he recorded that scientists considered deliberate insertion of the virus possible and agreed it required further expert review, despite later public recommendations suggesting the contrary.

He later privately questioned CDC and FDA competence, admitted officials had overstated mask ineffectiveness and repeatedly described testing and supply failures.

FAUCI’S NEWLY RELEASED COVID DIARIES REVEAL BIZARRE FIXATION ON FAME AS PANDEMIC DEATHS MOUNTED

Throughout his time as NIAID director, he made note of conversations, decisions and his thoughts about actions taken by politicians and other officials. What Paul released is Fauci’s historical record containing almost-daily entries.

“Later in the pandemic, he gloried in the positive attention he was receiving from legacy media and demonized those who questioned his official narrative — like me,” Paul said — alluding to heated exchanges during congressional hearings when Paul grilled Fauci over his pandemic response.

“Many entries in Fauci’s daily historical account completely undermine the official narrative that Fauci and other public health officials espoused,” Paul wrote in his introduction to the documents.

SLACK MESSAGES RELEASED BY RAND PAUL APPEAR TO SHOW AUTHORS OF KEY COVID-19 ORIGIN PAPER HELD PRIVATE DOUBTS

SIGN UP TO GET THE POLITICS NEWSLETTER

Paul said the “first alarm” went straight to the octogenarian immunologist, as he and two other medical experts examined the furin cleavage site in the virus and deliberated about the aforementioned genomic insertion and whether it truly escaped from a Chinese lab.

“Before most Americans knew there was an origins debate, the government’s top infectious-disease official was already confronting the lab scenario,” Paul said.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
EXCLUSIVE: Biden pardon won’t shield Fauci if he lies to Congress, Comer says
next post
J&J reaches sweeping talc deal that could end decade of litigation

related articles

Top union ‘cleared’ by law firm over explosive...

July 29, 2026

House progressives revive Green New Deal for public...

July 29, 2026

Top 5 moments from Fauci’s hearing: Paul boots...

July 29, 2026

Former Democratic staffers, DEI leaders shape Smithsonian leadership...

July 29, 2026

WATCH: Fetterman reveals his ‘one regret’ from COVID...

July 29, 2026

WATCH: Rand Paul says there’s one thing Americans...

July 29, 2026

‘Tip of the iceberg’: NJ illegal voting scandal...

July 29, 2026

Maine Dem in hot seat for championing popular...

July 29, 2026

‘They fed him his own ears’: Top Republican...

July 29, 2026

No Jews on Mamdani’s ‘truly representative’ NYC judiciary...

July 29, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • SK Hynix to raise $29.4B in US listing: How it may impact the AI memory chip trade

    June 24, 2026
  • Trump wins two, loses one: Georgia billionaire delivers rare blow to endorsement machine

    June 17, 2026
  • Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals

    June 30, 2026
  • FTSE 100 rises as Shell boosts energy stocks despite mining weakness

    July 7, 2026
  • China memory chipmaker CXMT’s shares soar in a blockbuster share listing in Shanghai

    July 27, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 3

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (354)
  • Investing (944)
  • Stock (43)

Latest Posts

  • Why smart money is fading Nvidia while rest of chips are soaring

    June 23, 2026
  • DAX Index nears crucial price after key Volkswagen, Rheinmetall, Bayer news

    June 26, 2026
  • Iran regime change talk resurfaces as Trump says Tehran ‘wants to meet’ amid US strikes

    July 22, 2026

Recent Posts

  • Nio stock is falling despite strong revenue growth: now what?

    June 23, 2026
  • Applied Materials, KLA stocks gain as AI boom lifts chip equipment outlook

    June 11, 2026
  • Trump proposes 20% cargo fee as US vows to police Strait of Hormuz

    July 13, 2026

Editor’s Pick

  • AeroVironment stock: Here’s why AVAV is pumping after earnings

    June 30, 2026
  • Here’s the key risk facing the Palo Alto Networks stock today

    July 7, 2026
  • Goldman Sachs stock soars after massive earnings beat shocks Wall Street

    July 14, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock